Traduction de «with » (Français → Néerlandais) :

TERMINOLOGIE

JS-R - Joubert syndrome with renal defect
syndroom van Joubert met renaal defect

AESD - acute encephalopathy with biphasic seizures and late reduced diffusion
acute encefalopathie met bifasische insulten en late gereduceerde diffusie

EMEA - eyelid myoclonia with and without absences
syndroom van Jeavons

JS-O - Joubert syndrome with ocular defect
syndroom van Joubert met oculair defect

TRADUCTIONS EN CONTEXTE

– with proteinuria and < 90 mmHg = 15.4 – with proteinuria and º 90 mmHg = 47.6 In black women (n = 2880): – without proteinuria and < 90 mmHg = 10.8 – without proteinuria and º 90 mmHg = 28.5 – with proteinuria and < 90 mmHg = 37.7 – with proteinuria and º 90 mmHg = 142.9
Middle trimester, stillbirth rate: In white women (n = 10,074): – without proteinuria and < 90mmHg = 8.4 – without proteinuria and º 90 mmHg = 14.8 – with proteinuria and < 90 mmHg = 15.4 – with proteinuria and º 90 mmHg = 47.6 In black women (n = 2880): – without proteinuria and < 90 mmHg = 10.8 – without proteinuria and º 90 mmHg = 28.5 – with proteinuria and < 90 mmHg = 37.7 – with proteinuria and º 90 mmHg = 142.9

Ventralight ST with Echo PS – Ellipse 15,2 cm x 20,3 cm = 242,34 cm² 5955680 Ventralight ST with Echo PS – Ellipse 15,2 cm x 25,4 cm = 340,00 cm² 5955610 Ventralight ST with Echo PS – Ellipse 17,8 cm x 22,9 cm = 320,14 cm² 5955790 Ventralight ST with Echo PS – Ellipse 20,3 cm x 25,4 cm = 404,97 cm² 5955810 Ventralight ST with Echo PS – Ellipse 25,4 cm x 33 cm = 658,32 cm² 5955113 Ventralight ST with Echo PS – Ellipse 30,5 cm x 35,6 cm = 1.085,80 5955124 cm²
Ventralight ST with Echo PS – Ellipse 15,2 cm x 20,3 cm = 242,34 cm² 5955680 Ventralight ST with Echo PS – Ellipse 15,2 cm x 25,4 cm = 340,00 cm² 5955610 Ventralight ST with Echo PS – Ellipse 17,8 cm x 22,9 cm = 320,14 cm² 5955790 Ventralight ST with Echo PS – Ellipse 20,3 cm x 25,4 cm = 404,97 cm² 5955810 Ventralight ST with Echo PS – Ellipse 25,4 cm x 33 cm = 658,32 cm² 5955113 Ventralight ST with Echo PS – Ellipse 30,5 cm x 35,6 cm = 1.085,80 cm² 5955124

Kim C et al - Am.Heart J. 46 2001 meta analysis yes 82 studies Coronary disease diagnostic : maximum sensitivity with vasodilatator combined with SPECT, maximum specificity with vasodilatator combined with DSE.
Kim C et al - Am.Heart J. 44 2001 meta analysis yes 82 studies Coronary disease diagnostic : maximum sensitivity with vasodilatator combined with SPECT, maximum specificity with vasodilatator combined with DSE.

Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease perioperative risks ii . NICE Minor surgery: ASA I : not indicated ASA II : consider > 40 y if respiratory or CV disease ASA III : consider if respiratory or CV disease Intermediate surgery: ASA I : not indicated ASA II : consider if respiratory or CV disease (renal > 60y) ASA III : consider if respiratory, CV or renal disease Major surgery: ASA I : consider > 60 ASA II : consider if respiratory, CV or renal disease ASA III : consider if respiratory, CV or renal disease
Source Statement ACA Not included ACP Not included ASA Selected patients : Agreement : 90 % of consultants, 92 % ASA Members To consider : smoking, recent infection, COPD, and cardiac disease ICSI Selected patients with signs or symptoms suggesting new or unstable cardiopulmonary disease INAHTA Chest X-ray abnormality correspond more closely with ASA status than with age (McCleane) i The results of between 0% and 2.1% of chest X-rays leads to a change in management There is no published evidence that routine preoperative chest X-rays decrease

JAMA 2002 ; 288 : 2981-2997 (6) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other first-line antihypertensive therapies : a meta-analysis of randomised controlled trials.
JAMA 2002 ; 288 :2981-2997 (6) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other first-line antihypertensive therapies : a meta-analysis of randomised controlled trials.

The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002 ; 288 : 2981-2997 (5) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other firstlineantihypertensive therapies : a meta-analysis of randomised controlled trials.
The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT).JAMA 2002; 288: 2981-2997 (5) PAHOR M, PSATY B, ALERMAN M et al. Health outcomes associated with antagonists compared with other firstline antihypertensive therapies : a meta-analysis of randomised controlled trials.

65. Fowler VG Jr, Sanders LL, Sexton DJ et al : Outcome of Staphylococcus aureus bacteremia according to compliance with recommandations of infectious diseases specialists : expérience with 244 patients.
65. Fowler VG Jr, Sanders LL, Sexton DJ et al: Outcome of Staphylococcus aureus bacteremia according to compliance with recommandations of infectious diseases specialists: experience with 244 patients.

Code d’identification Nom du produit Nouveau nom du produit 105003000103 Nucleus 24 Contour Advanced Nucleus 24 Contour Advanced with Softip with Softip - CI24R (CA)
Identificatiecode Productnaam Nieuwe productnaam 105003000103 Nucleus 24 Contour Advanced with Nucleus 24 Contour Advanced with Softip - CI24R (CA) Softip - CI24R (CA) implantaat

“HiRes 90K Advantage Cochlear Implant with HiFocus 1J electrode”; “HiRes 90K Advantage Cochlear Implant with HiFocus Helix electrode”.
“HiRes 90K Advantage Cochlear Implant with HiFocus 1J electrode” “HiRes 90K Advantage Cochlear Implant with HiFocus Helix electrode”.

a requirement that manufacturers fit their devices with a Unique Device Identification (UDI) which allows traceability.
de fabrikanten moeten hun devices voorzien van een unieke identificatiecode die de traceerbaarheid ervan moet toelaten.